Clinical Trials Browser

Metastatic Pancreatic Adenocarcinoma × ibrutinib × Clear all

NCT02562898 2021-05-06

Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

Phase 1/2 Completed

18 enrolled 15 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma